Profile data is unavailable for this security.
About the company
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
- Revenue in SEK (TTM)15.48m
- Net income in SEK-3.93m
- Incorporated2004
- Employees8.00
- LocationInhalation Sciences Sweden ABHalsovagen 7, Novum Floor 6, Elevator EHUDDINGE 141 57SwedenSWE
- Phone+46 85 468845846
- Websitehttps://www.inhalation.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perpetua Medical AB (publ) | 6.32m | -8.48m | 21.68m | 0.00 | -- | 2.10 | -- | 3.43 | -3.06 | -3.06 | 1.91 | 2.28 | 0.4074 | 16.13 | 6.19 | -- | -54.70 | -83.52 | -74.20 | -102.19 | -65.03 | -70.52 | -134.27 | -250.30 | 6.39 | -- | 0.00 | -- | -1.76 | 57.20 | 4.63 | -- | 8.89 | -- |
S2Medical AB (publ) | 10.57m | -1.86m | 22.35m | 17.00 | -- | 0.971 | -- | 2.12 | -0.0193 | -0.0193 | 0.0333 | 0.0273 | 0.3356 | 0.2926 | 5.53 | 621,550.00 | -5.91 | -65.16 | -14.21 | -101.50 | 89.45 | 65.03 | -17.62 | -220.19 | 0.4329 | 0.541 | 0.00 | -- | 49.27 | 36.05 | 22.91 | -- | -14.81 | -- |
Level Bio AB (publ) | 24.23m | -12.18m | 22.82m | 13.00 | -- | 4.76 | -- | 0.9419 | -0.1921 | -0.1921 | 0.3822 | 0.0757 | 1.29 | 4.98 | 9.81 | 1,863,894.00 | -65.05 | -6.39 | -105.55 | -10.51 | 2.57 | -- | -50.26 | -4.09 | 0.6867 | -596.55 | 0.00 | -- | -23.10 | 7.83 | -326.08 | -- | -4.64 | -- |
Invent Medic Sweden AB | 6.73m | -8.04m | 24.46m | 9.00 | -- | 5.02 | -- | 3.64 | -0.1939 | -0.1939 | 0.1613 | 0.0566 | 0.6084 | 2.31 | 4.34 | 841,046.30 | -72.67 | -97.56 | -133.97 | -121.06 | 77.43 | 77.16 | -119.45 | -490.98 | 0.3951 | -12.43 | 0.2703 | -- | 115.97 | 177.53 | 28.77 | -- | -22.61 | -- |
Miris Holding AB (publ) | 17.32m | -9.41m | 28.98m | 10.00 | -- | 3.73 | -- | 1.67 | -0.2092 | -0.2092 | 0.3641 | 0.0271 | 0.824 | 0.1117 | 7.25 | 1,732,100.00 | -44.74 | -59.61 | -95.35 | -111.08 | 97.83 | 86.68 | -54.30 | -103.61 | 0.7091 | -8.08 | 0.0903 | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
Medimi AB | 4.18m | -13.64m | 29.44m | 6.00 | -- | 1.09 | -- | 7.04 | -0.0157 | -0.0157 | 0.0047 | 0.0072 | 0.3095 | 0.9145 | 2.27 | 696,481.70 | -101.01 | -81.87 | -126.70 | -93.93 | 40.84 | 4.06 | -326.40 | -840.93 | 2.52 | -46.18 | 0.279 | -- | 75.13 | 280.69 | 7.52 | -- | -- | -- |
Chordate Medical Holding AB (publ) | 1.12m | -27.82m | 34.11m | 3.00 | -- | 1.64 | -- | 30.37 | -41.97 | -41.97 | 1.67 | 21.16 | 0.0363 | -0.746 | 3.53 | 374,390.00 | -90.02 | -91.98 | -110.15 | -122.85 | 219.20 | 209.52 | -2,477.25 | -3,295.75 | 2.34 | -- | 0.00 | -- | 799.63 | 0.6511 | -4.45 | -- | -- | -- |
Inhalation Sciences Sweden AB | 15.48m | -3.93m | 37.92m | 8.00 | -- | 3.37 | -- | 2.45 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
Scandinavian Real Heart AB | 0.00 | -75.02m | 39.50m | 12.00 | -- | 0.4317 | -- | -- | -0.5182 | -0.5182 | 0.00 | 0.4425 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
Scandinavian ChemoTech AB | 4.61m | -16.98m | 43.38m | 6.00 | -- | 10.98 | -- | 9.40 | -1.04 | -1.04 | 0.2749 | 0.1821 | 0.2583 | 0.518 | 1.17 | 768,833.30 | -95.08 | -87.29 | -95.08 | -118.55 | 32.45 | 252.05 | -368.11 | -2,122.77 | -- | -14.56 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
ProstaLund AB | 17.57m | -21.64m | 44.91m | 6.00 | -- | 0.6453 | -- | 2.56 | -0.2752 | -0.2752 | 0.2226 | 0.5656 | 0.2627 | 0.3308 | 12.78 | -- | -32.35 | -29.14 | -39.54 | -35.01 | 72.73 | 75.26 | -123.16 | -68.94 | 0.7618 | -155.80 | 0.1065 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
Bio Vitos Pharma AB | 1.11m | -14.84m | 47.28m | 1.00 | -- | 1.33 | -- | 42.64 | -0.1498 | -0.1498 | 0.006 | 0.0905 | 0.0457 | 0.092 | 3.02 | 1,108,910.00 | -61.08 | -31.11 | -62.90 | -32.92 | 90.59 | -- | -1,338.03 | -1,026.76 | 5.84 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
iZafe Group AB | 4.77m | -31.86m | 56.65m | 8.00 | -- | 2.76 | -- | 11.88 | -0.1332 | -0.1332 | 0.0202 | 0.0747 | 0.1111 | 2.67 | 3.41 | 681,285.70 | -74.23 | -52.17 | -85.90 | -69.40 | -167.81 | -198.20 | -668.02 | -487.50 | 0.6358 | -- | 0.1085 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |